Bonni Goldstein
Chief Medical Advisor, USA / Neurotech International
| Rank | Company | # | |
|---|---|---|---|
| 115th | - | Neurotech International | $2.44m |
| 124th | - | Zimi | $1.56m |
| 125th | - | 333D | $1.51m |
| 126th | - | Peppermint Innovation | $1.37m |
| 127th | - | Zelira Therapeutics | $1.16m |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1584th | FBR | -60% | -33.17% |
| 1585th | ImpediMed | -60.57% | -32.92% |
| 1586th | Neurotech International | -60.59% | -28.79% |
| 1587th | Dubber Corporation | -61.11% | -59.89% |
| 1588th | Syntara | -61.3% | -17.45% |
|
NEW ROLE: Chief Medical Advisor, USA, Neurotech International | 25 Jun 2025 |
Access to our data for Bonni Goldstein is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Bonni Goldstein is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.